Ferring Pharma bags USFDA approval for Adstiladrin to treat Bladder Cancer Ruchika Sharma17 Dec 2022 3:58 PM ISTAdstiladrin, an intravesical therapy administered every three months, targets the patient's own bladder wall cells to enhance the body's natural...
Metabolic syndrome linked with elevated risk of bladder cancer Medha Baranwal29 Oct 2022 12:00 PM ISTChina: Metabolic syndrome (MetS) is associated with an elevated risk of bladder cancer in the general population, a recent study in Frontiers in...
SGLT2 inhibitors not linked to increased bladder cancer risk: Study Jacinthlyn Sylvia19 Oct 2022 8:15 PM ISTA recent study by Devin Abrahami published in the journal of Diabetes Care found that sodium-glucose cotransporter 2 (SGLT2) inhibitors are not...
Bladder cancer and its declining awareness Isra Zaman27 Sept 2022 9:45 AM ISTCancers are on a rise in India and bladder cancer is the 9th most common and leading cause of cancer in the country.However in few countries like...
Medical Bulletin 13/September/2022 Isra Zaman13 Sept 2022 12:07 PM ISTHere are the top medical news for the day:Immunotherapy before surgery helpful for common skin cancer patients: StudyIn an international, multicenter...
Immune cell that helps to kill bladder cancer tumors identified Isra Zaman13 Sept 2022 10:00 AM ISTMount Sinai researchers have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the immune system. The...
Combining chemotherapy and radiotherapy has long term benefit in bladder cancer Dr. Kamal Kant Kohli7 Aug 2022 8:00 PM ISTGiving people with bladder cancer chemotherapy and radiotherapy at the same time helps stop cancer from coming back, long-term results of a 10-year...
Intravesical chemotherapy combination provides effective treatment alternative for high-risk non-muscle invasive bladder cancer Dr. Kamal Kant Kohli1 Aug 2022 8:00 PM ISTA combination of two intravesical chemotherapy drugs-gemcitabine and docetaxel-yields high response rates with good tolerability in patients with...
Atezolizumab to help survival in bladder cancer patients with ctDNA positivity Isra Zaman7 July 2022 9:45 AM ISTResearchers treated a group of post-surgery bladder cancer patients with the immunotherapy drug atezolizumab and have found that patients whose...
Prophylactic Levofloxacin lowers adverse events in bladder cancer patients treated with BCG therapy Jacinthlyn Sylvia1 July 2022 7:30 PM ISTJapan: A new study published in European Urology Focus shows that in individuals with non-muscle-invasive bladder cancer (NMIBC), prophylactic...
BCG infections after BCG instillation therapy on the rise in bladder cancer patients Jacinthlyn Sylvia29 Jun 2022 7:30 PM ISTFinland: In a new study published in British Journal of Urology International, it was shown that the prevalence of Bacille Calmette-Guérin (BCG)...
Levofloxacin safe and effective therapy for bladder cancer patients treated with BCG therapy: Study Medha Baranwal20 Jun 2022 8:00 PM ISTJapan: The administration of prophylactic levofloxacin may reduce the severity of adverse outcomes in non-muscle-invasive bladder cancer (NMIBC)...
